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Aims The differentiation between idiopathic right ventricular outflow tract (RVOT) arrhythmias and early arrhythmogenic
right ventricular cardiomyopathy (ARVC) can be challenging. We aimed to assess whether QRS morphological features
and coupling interval of ventricular ectopic beats (VEBs) can improve differentiation between the two conditions.
Methods
and results
Twenty desmosomal-gene mutation carriers (13 females, mean age 43 years) with no or mild ARVC phenotypic ex-
pression and 33 age- and sex-matched subjects with idiopathic RVOT arrhythmias were studied. All patients exhibited
isolated monomorphic VEBs with left bundle branch block/inferior axis morphology. The predictive value of ectopic
QRS morphology and coupling interval was evaluated. Five ectopic QRS features were significantly more common in
desmosomal-gene mutation carriers than in idiopathic RVOT-ventricular arrhythmia patients: maximal QRS duration
.160 ms (60 vs. 27%, P ¼ 0.02), intrinsicoid deflection time .80 ms (65 vs. 24%, P ¼ 0.01), initial QRS slurring (40 vs.
12%, P ¼ 0.04), QS pattern in lead V1 (90 vs. 36%, P, 0.001), and QRS axis .908 in limb leads (60 vs. 24%, P ¼ 0.01).
In the multivariate analysis, intrinsicoid deflection time .80 ms [odds ratio (OR) ¼ 9.9], QS pattern in lead V1
(OR ¼ 28), and QRS axis .908 (OR ¼ 5.7) remained independent predictors of early ARVC. The coupling interval
did not differ between the two groups.
Conclusions In patients with RVOT VEBs and no major electrocardiographic or echocardiographic abnormalities, the ectopic QRS
morphology aids in the differential diagnosis between idiopathic RVOT arrhythmias and early ARVC.
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Introduction
In the majority of patients, ventricular ectopic beats (VEBs) with a
left bundle branch block/inferior axis configuration, suggesting a
right ventricular outflow tract (RVOT) origin, are benign and idio-
pathic.1 In a minority of cases, however, those VEBs may be the
expression of an underlying arrhythmogenic right ventricular car-
diomyopathy (ARVC), a genetically determined heart muscle
disease predisposing to ventricular arrhythmias (VA) and sudden
death.2,3
Previous studies focusing on electrocardiographic criteria for dif-
ferential diagnosis between cardiomyopathy-related and idiopathic
RV arrhythmias included patients with definite ARVC and overt
structural cardiomyopathic changes.4 – 13 Therefore, this differenti-
ation from patients with idiopathic RVOT-VAs, who demonstrate
a structurally normal heart, is usually straightforward without the
need for complex analysis of the ectopic QRS morphology.14 How-
ever, genetically affected patients with early ARVC phenotypic ex-
pression may show VEBs with a left bundle branch block/inferior
axis configuration and no or only minor abnormalities on ECG/
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echocardiography, thus mimicking idiopathic RVOT arrhythmias.15
Differentiation between the two conditions is particularly important
because electrical instability and sudden cardiac death may occur in
ARVC patients before the disease becomes fully manifest.
The aim of the study was to compare the QRS morphology and
the coupling interval of VEBs with a left bundle branch block/inferior
axis morphology between pathogenic desmosomal-gene mutation
carriers with early phenotypic expression (i.e. no or minor ARVC
features at ECG and echocardiography) and subjects with idiopathic
RVOT arrhythmias and structurally normal hearts. We hypothe-
sized that the QRS morphology can differentiate between the two
subgroups of patients.
Methods
Early arrhythmogenic right ventricular
cardiomyopathy patients
The early ARVC cohort was recruited at the Heart Hospital, University
College of London Trust, UK (N ¼ 12) and the Department of Cardiac,
Thoracic, and Vascular Sciences, University of Padova, Italy (N ¼ 8),
which are tertiary care hospitals with dedicated inherited arrhythmo-
genic cardiomyopathy units. Patients were included if they fulfilled all
the following criteria: (i) demonstration of a pathogenic desmosomal
gene, according to the previously described criteria;14,16,17 (ii) recording
of ≥10 isolated monomorphic VEBs with a left bundle branch block/in-
ferior axis at 12-lead 24 h ECG Holter monitoring; and (iii) absence of
major diagnostic criteria and two or less minor criteria for ARVC diag-
nosis, according to the 2010 International Task Force Criteria.14
Idiopathic right ventricular outflow tract
arrhythmias
The study enrolled a consecutive series of 33 individuals, matched for
age and gender with early ARVC patients, who underwent ablation of
monomorphic RVOT VEBs at the Heart Hospital during 2012–13. Sub-
jects were included if they had: (i) negative family history of sudden car-
diac death or ARVC; (ii) diagnosis of structurally normal heart after
complete clinical evaluation (including contrast-enhanced cardiac mag-
netic resonance in selected cases); (iii) absence of low-voltage electro-
gram areas at endocardial voltage mapping; and (iv) successful ablation
of ectopics in the RVOT.
Electrocardiogram analysis
Standard 12-lead ECGs were obtained using the traditional lead posi-
tioning and recorded at 1 mV/cm and 25 mm/s paper speed. The traces
were digitally acquired, and each measurement was performed with
digital calipers after magnification. In sinus rhythm, the analysis focused
on the following minor ECG abnormalities associated with ARVC:
(i) delayed S-wave upstroke in leads V1–V3 (.60 ms from nadir of
S wave to baseline) in the absence of complete right bundle branch
block; (ii) negative T-waves ≥0.1 mV in depth in V1 and V2; (iii) negative
T-waves ≥0.1 mV in depth in two contiguous leads V4–V6; and (iv) low
QRS voltage in limb leads (≤0.5 mV). The ectopic beats morphology
and coupling interval were analysed on 12-lead 24 h ECG-Holter mon-
itoring. The morphology analysis of the ectopic QRS focused on the
following characteristics: (i) presence of QRS notching in one or
more leads; (ii) presence of multiple QRS notching (two or more leads);
(iii) maximal QRS duration .160 ms; (iv) intrinsicoid deflection time
.80 ms in one or more leads, defined as the time between the QRS on-
set and the peak of the R-wave or the nadir of the Q-wave; (v) initial
slurring (‘pseudo-delta’) in one or more leads, defined as the time be-
tween the QRS onset and earliest fast QRS deflection; (vi) precordial
transition, defined as the precordial lead in which the R-wave amplitude
is greater than equal to S-wave amplitude; (vii) QS morphology in leads
V1 and V2, defined as the absence of positive QRS deflections; (viii) pre-
dominantly negative QRS in lead 1; (ix) presence of Q wave in lead 1,
defined as an initial negative QRS deflection; and (x) QRS duration
.120 ms in lead 1. To determine the onset and termination of the
QRS, when a sharp deflection or offset was not seen, we used the inter-
section of the downslope or upslope of the QRS morphology with the
isoelectric line.
For the coupling interval analysis, we evaluated 10 consecutive mono-
morphic VEBs recorded during sinus rhythm with a rate between 60 and
80 b.p.m. The ECG interpretation was performed independently by two
observers who were blinded for the clinical diagnosis (J.N. and A.Z.);
in the case of disagreement, a third observer (S.C.) was consulted.
Echocardiography
Echocardiography, which was performed at the time of enrolment by
operators experienced in the evaluation of patients with cardiomyop-
athies, focused on the RV and included measurements of overall RV
size and function, as well as description of regional dilation or wall mo-
tion abnormalities. According to the 2010 ITF criteria,14 a combination
of regional wall motion abnormalities in one or more RV segments and
either mild RVOT dilation (29–32 mm in long-axis view or 26–32 mm
in short-axis view) or mild global RV dysfunction (fractional area change
33–40%) was considered a minor diagnostic criterion for ARVC.
Statistical analysis
Continuous variables were reported as median (25–75th percentiles)
and compared with the rank-sum test because normality could not be
assumed for any variable. Categorical variables were analysed with the
x2 test or the Fisher’s exact test, as appropriate. Two-tailed, 95% con-
fidence interval (CI) of sensitivity, specificity, and negative and predictive
values were calculated on the basis of the binomial distribution.
What’s new
† The long-term (8.5 years) arrhythmic risk of DS-gene muta-
tion carriers, with no prior sustained ventricular tachycardia
or fibrillation, is strongly related to the ARVC phenotypic ex-
pression and the presence of major risk factors such as syn-
cope, ventricular dysfunction, or non-sustained ventricular
tachycardia.
† The study results do not support the concept that DS-gene
carriers may experience life-threatening arrhythmic events
before and/or regardless of the development of ARVC
phenotypic features (‘concealed phase’), as postulated on
the basis of experimental studies showing that lethal arrhyth-
mogenic mechanisms may arise at a molecular/cellular level
as a result of a cross-talk of altered desmosomes with sodium
channel and gap junction proteins.
† Our findings also suggest that the ‘concealed phase’ of the
disease may be the result of the low sensitivity of routine clin-
ical tests (i.e. ECG and echocardiography) for the detection
of early/minor disease phenotypic manifestations such as iso-
lated epicardial scar involvement of the left ventricle, rather
than expression of a subcellular arrhythmogenic mechanism.
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Variables with a P-value ,0.15 at univariate analysis were entered into a
multivariate binary logistic regression model. The inter-observer agree-
ment was evaluated by the Cohen kappa statistic test. The ECG para-
meters, which were independently correlated to the diagnosis of early
ARVC, were used to build a score system (one point each variable). This
new model was compared with the score model proposed by Hoff-
mayer et al.,11 which assigned one point to each of the following vari-
ables: QRS duration .120 ms in lead 1, multiple QRS notching, and
precordial transition in V5 or later. The score system of Hoffmayer
et al. also assigned 3 points to the presence of anterior T-wave inversion
(TWI) extending to V3, but according to our study design, no patients
exhibited this feature as this is a major ARVC diagnostic criterion. The
receiver operating characteristic (ROC) curves obtained by the two
score models were compared with the method of DeLong et al. A two-
tailed P, 0.05 was considered statistically significant. All analyses were
performed using SPSS 17 (SPSS Inc., Chicago, IL, USA).
Results
Clinical characteristics of the study population are shown in Table 1.
There were no statistically significant differences in the prevalence of
ECG abnormalities between early ARVC and idiopathic RVOT arrhyth-
mia patients. The ECG was completely normal in 12 (60%) early ARVC
and in 27 (82%) idiopathic RVOT arrhythmia patients (P¼ 0.08). As per
inclusion criteria, echocardiography was normal in all idiopathic RVOT
arrhythmia patients, whereas a combination of regional wall motion ab-
normalities and mild RVOT dilation or mild global RV dysfunction (min-
or ARVC diagnostic criterion) was present in five (20%) early ARVC
patients. Arrhythmogenic right ventricular cardiomyopathy patients
showed a mean of 0.8 minor diagnostic criteria and, as per inclusion cri-
teria, no major diagnostic criteria.
The comparison between ectopic QRS morphology and coupling
interval between early ARVC and idiopathic RVOT arrhythmia pa-
tients is shown in Table 2. Five ectopic QRS features were signifi-
cantly more common in early ARVC than in RVOT arrhythmia
patients: maximal QRS duration.160 ms (60 vs. 27%, P ¼ 0.02), in-
trinsicoid deflection time.80 ms (65 vs. 24%, P ¼ 0.01), initial QRS
slurring (40 vs. 12%, P ¼ 0.04), QS pattern in lead V1 (90 vs. 36%,
P, 0.001), and predominantly negative QRS complex in lead 1
(60 vs. 24%, P ¼ 0.01). At the multivariate analysis (Table 3), intrin-
sicoid deflection time .80 ms [odds ratio (OR) ¼ 9.9], QS pattern
in lead V1 (OR ¼ 28), and predominantly negative QRS complex in
lead 1 (OR ¼ 5.7) remained independent predictors of early ARVC.
Sensitivity, specificity, and positive and negative predictive values
of the three ECG criteria that were found to independently predict
ARVC mutation carriage are shown in Table 4. QS morphology in
lead V1 showed the highest sensitivity (90%, 95% CI 68–99), where-
as intrinsicoid deflection time .80 ms and predominantly negative
QRS morphology in lead 1 had the highest specificity (76%, 95% CI
58–89). The combination of all three criteria (Figure 1) showed a
sensitivity of 55% (95% CI 32–78), a specificity of 91% (95% CI
76–98), a positive predictive value of 79% (95% CI 49–95), and a
negative predictive value of 77% (95% CI 61–89).
Inter-observer agreement was 100% for QRS axis .908 and QS in
lead V1, 96% for intrinsicoid deflection time .80 ms (kappa¼ 0.92,
P, 0.001), 94% for maximal QRS duration .160 ms (kappa¼ 0.88,
P, 0.001), and 92% for initial QRS slurring (kappa¼ 0.80, P, 0.001).
The comparison between the accuracy of the score system pro-
posed by Hoffmayer et al. and our new scoring system including the
three variables that were independently associated with early ARVC
diagnosis in the present study is shown in Table 5. The number of
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Table 1 Clinical characteristics of patients with early ARVC and with idiopathic RVOT-VT
Early ARVC (N 5 20) Idiopathic RVOT-VA (N 5 33) P-value
Age (years) 43 (26–54) 39 (30–45) 0.82
Gender (male) 13 (70) 23 (70) 1.0
History
Palpitations 8 (40) 27 (82) 0.003
Chest pain 3 (15) 2 (6) 0.35
Pre-syncope 5 (25) 8 (24) 0.95
Syncope 5 (25) 8 (24) 0.95
Baseline ECG findings
S-wave .60 ms in V1–V3 4 (20) 2 (6) 0.18
Negative T-waves in V1 and V2 4 (20) 3 (9) 0.40
Negative T-waves in V4–V6 0 1 (3) 1.0
Low (≤0.5 mV) QRS voltages in limb leads 2 (10) 0 1.0
Echocardiographic findings
Regional RV WMA 13 (65) 0 ,0.001
RVOT WMA 1 (5) 0 1.0
RVOT long axis 29–32 mm 6 (30) 0 0.002
RVOT short axis 32–36 mm 0 0 –
RV FAC 33–40% 2 (10) 0 1.0
ARVC, arrhythmogenic right ventricular cardiomyopathy; FAC, fractional area change; RV, right ventricular; RVOT, right ventricular outflow tract; WMA, wall motion abnormalities.
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points was similar between early ARVC and idiopathic RVOT-VA
patients [1 (0–2) vs. 1 (0–1), P ¼ 0.63] using the score of Hoff-
mayer et al.,11 although it was significantly higher in ARVC than in
idiopathic RVOT-VA patients [3 (2–3) vs. 0 (0–2), P, 0.001] using
the new score model. The area under the ROC curve of the new
score model was significantly higher than that under the ROC
curve of the score of Hoffmayer et al. [0.84 (0.73–0.95) vs. 0.54
(0.37–0.70), P ¼ 0.007].
Discussion
This study was designed to compare the VEBs morphology and coup-
ling interval in a series of patients with early ARVC phenotypic
expression, defined as the presence of pathogenic desmosomal-gene
mutation and no major electrocardiographic or echocardiographic
ARVC features, and in a group of gender- and age-matched patients
with idiopathic RVOT arrhythmia patients. The main findings were as
follows: (i) patients with early ARVC may have VEBs with a left bundle
branch block/inferior axis as the only phenotypic manifestation of the
disease, mimicking idiopathic RVOT arrhythmias, and (ii) the combin-
ation of QS morphology in lead V1, predominantly negative QRS
complex in lead 1, and intrinsicoid deflection time .80 ms showed
a high specificity for an underlying cardiomyopathy.
In the general population, RVOT VEBs are usually ‘idiopathic’ (i.e.
unrelated to structural heart disease) and carry a benign prognosis,1
but in a minority of cases, they can be the expression of an under-
lying ARVC, a genetically determined cardiomyopathy characterized
by desmosomal-protein dysfunction leading to progressive fibro-
fatty infiltration, ECG abnormalities, VAs, and regional and/or global
ventricular dysfunction.2,3,15 Although in the ‘overt’ phase of ARVC,
differentiation with idiopathic RVOT-VT is usually straightforward;
as ECG and echocardiographic abnormalities are prominent,
desmosomal-gene mutation carriers with early ARVC phenotypic
expression may show VEBs with a left bundle branch block/inferior
axis configuration as the only feature of the disease, thus mimicking
idiopathic RVOT arrhythmias.15
The arrhythmogenic substrate of ARVC-related and idiopathic
VEBs is different. Although the characteristic of idiopathic RVOT ar-
rhythmias is the absence of underlying cardiac disease, resulting in
focal origin of ectopic beats, caused by a relatively small cluster of
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Table 2 Comparison between electrocardiographic findings at admission in patients with early ARVC and idiopathic
RVOT-VA
Early ARVC (N520) Idiopathic RVOT-VA (N533) P-value
Age (years) 43 (26–54) 39 (30–45) 0.82
Gender (male) 13 (70) 23 (70) 1.0
Ectopic morphology
Maximal QRS duration .160 ms 12 (60) 9 (27) 0.02
QRS axis .908 12 (60) 8 (24) 0.01
QRS notching in one or more leads 14 (70) 26 (79) 0.47
QRS notching in two or more leads 10 (50) 15 (45) 0.75
Intrinsicoid deflection time .80 ms 12 (60) 8 (24) 0.01
Initial slurring (pseudo-delta) 8 (40) 4 (12) 0.04
Precordial transition ≥V4 11 (55) 17 (52) 1.0
Precordial transition ≥V5 3 (15) 4 (12) 1.0
QS morphology in lead V1 18 (90) 12 (36) <0.001
QS morphology in lead V2 10 (50) 8 (24) 0.06
Q-wave in lead 1 5 (25) 10 (30) 0.76
QRS duration .120 ms in lead 1 6 (30) 7 (21) 0.52
Ectopic coupling
Max interval sQRS-eQRS (ms) 540 (500–600) 480 (440–560) 0.12
Min interval sQRS-eQRS (ms) 420 (360–500) 400 (380–420) 0.23
Max–min sQRS-eQRS (ms) 100 (40–140) 60 (40–150) 0.71
Variance (ms) 32 (15–54) 24 (15–41) 0.65
ARVC, arrhythmogenic right ventricular cardiomyopathy; eQRS, QRS of the ventricular ectopic beat; sQRS, QRS at sinus rhythm.
Bold values depict characteristics with significant P-values.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Multivariable ECG predictors for the diagnosis
of early arrhythmogenic cardiomyopathy
OR 95% CI P-value
QRS .160 ms 1.3 0.2–8.6 0.8
QRS axis .908 5.7 1.0–32 0.048
Intrinsicoid deflection .80 ms 9.9 1.1–90 0.037
Initial slurring (pseudo-delta) 2.9 0.3–24 0.3
QS morphology in lead V1 27.8 3.0–255 0.003
Bold values depict characteristics with significant P-values.
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cells showing enhanced automaticity in the context of a healthy
myocardium, ARVC VEBs are caused by triggered activity of elec-
trically isolated myocytes interspersed among fibrofatty tissue18
or re-entry.6 Recent pre-clinical studies have disclosed novel
arrhythmic mechanisms in the early ARVC phase: it has been de-
monstrated that the genetically determined loss of expression of
the desmosomal proteins may alter the amplitude and kinetics
of sodium current and lead to a decrease in total content and a sig-
nificant redistribution of Cx43, thus predisposing to the develop-
ment of electrical instability unrelated to structural myocardial
changes.17,19 – 21 Desmosomal uncoupling and fibrosis may slow
propagation through the myocardium and impact upon surface
ECG QRS complex generation. The site of origin is also different
in the two conditions: idiopathic RVOT VEBs usually arise from
the endocardial and septal portions of the RVOT, whereas the
source of ARVC-related VEBs is typically the epicardial layer of
the anterior wall.1,2,22,23
The different pathophysiological mechanisms, substrate features,
and site of VEBs origin in the two conditions may account for differ-
ent morphological features of the ectopic QRS complex on surface
ECG. Accordingly, several studies investigated whether simple ECG
criteria help in the differentiation of VAs in overt ARVC from idio-
pathic RVOT. Ainsworth et al.8 compared 20 patients with overt
ARVC and 24 with idiopathic RVOT ventricular tachycardia (VT)
and found that QRS duration .120 ms in lead I coupled with
QRS axis ,308 was a sensitive and specific marker for the diagnosis
of ARVC. Based on a previous retrospective study from the same
group,10 Hoffmayer et al.11 developed a scoring system to distin-
guish QRS morphology in ARVC patients with arrhythmias (either
VT or VEBs) with a left bundle branch block/inferior axis and pa-
tients with idiopathic RVOT arrhythmias. Criteria for differential
diagnosis included anterior TWIs (V1–V3) in sinus rhythm (3
points), lead I ectopic QRS duration .120 ms (2 points), ectopic
QRS notching in multiple leads (2 points), and R/S transition of
the ectopic QRS in V5 or later (1 point). A score higher than 5 pre-
dicted ARVC with a sensitivity of 84% and a specificity of 100%.
However, the results of these studies were of limited clinical value
because they mostly referred to overt ARVC patients, whose ECG
and echocardiographic findings are easily distinguishable from those
of patients with idiopathic RVOT arrhythmia without the need for
analysing the morphology of the ectopic beats. Furthermore, the
majority of ARVC patients presented with VT, a clinical scenario
that justifies the use of invasive investigations, such as endocardial
voltage mapping, which can differentiate between idiopathic
RVOT and early ARVC through the identification of ‘low voltages
areas’, corresponding to regions of fibrofatty replacement. In con-
trast, in the evaluation of patients with isolated VEBs, clinicians often
have to rely only on ECG and imaging to exclude an underlying
ARVC.
Our study is the first to enrol desmosomal-gene mutation car-
riers with isolated VEBs with a left bundle branch block/inferior
axis configuration and no or minor ARVC electrocardiographic
and echocardiographic features of the disease, i.e. the clinical scen-
ario that actually raises problems of differential diagnosis with idio-
pathic RVOT VEBs. We found that intrinsicoid deflection time (the
time between the QRS onset and the peak of the R-wave or the
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Table 4 Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with 95% CIs of
different ECG criteria for the diagnosis of early arrhythmogenic cardiomyopathy
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
QRS axis .908 60 (36–81) 76 (58–89) 60 (36–81) 76 (58–89)
Intrinsicoid deflection time .80 ms 60 (36–81) 76 (58–89) 60 (36–81) 76 (58–89)
QS morphology in lead V1 90 (68–99) 64 (45–80) 60 (41–77) 91 (72–99)
All three criteria 55 (32–78) 91 (76–98) 79 (49–95) 77 (61–89)
V6
A
B V6
V1
V1
L1
L1
Figure 1 One representative example of ECG leads V6, V1, and
1 in a patient with early ARVC (A) and in a patient with idiopathic
RVOT arrhythmia (B). In lead V6, the dotted lines identified an
80 ms interval after the beginning of the QRS. The intrinsicoid de-
flection time is .80 ms in the early ARVC patient, whereas it is
≤80 ms in the patient with idiopathic RVOT arrhythmia. In lead
V1, there is a QS morphology in the early ARVC patient but not
in the idiopathic RVOT arrhythmia patient. In lead 1, a Q-wave is
observed only in the early ARVC patient. The co-existence of all
three factors has a sensitivity of 55% and a specificity of 91% for
early ARVC.
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nadir of the Q-wave) .80 ms, QS morphology in lead V1, and axis
.90% were VEB features that were independently associated with
the diagnosis of ARVC. The delayed intrinsicoid deflection in ARVC
patients may be explained by: (i) the delayed conduction because of
segmental fibrofatty replacement and/or secondary sodium channel
dysfunction and (ii) the epicardial origin of the VEBs, as it has been
demonstrated that epicardial VAs typically show delayed intrinsicoid
deflection.24 Instead, QS morphology in lead V1 and negative QRS
polarity in lead 1 are typical features of arrhythmias arising from the
anterior RVOT wall near the pulmonary valve rather than the septal/
postero-septal RVOT region.1,23 This finding is consistent with a
study on electroanatomical mapping in patients with early ARVC,
showing that the majority of patients with an abnormal mapping
had electroanatomical scars confined to the antero-infundibular
free wall.2
Although no single feature was accurate enough to allow differential
diagnosis, the combination of these three criteria was highly specific
(91%) for early ARVC. The new score system that we could build using
these three criteria demonstrated good diagnostic accuracy (area un-
der ROC curve ¼ 0.84). Instead, we did not confirm the diagnostic va-
lues of VEB features such as QRS duration in lead I, multiple QRS
notching, and QRS transition ≥V5 transition, and, as a result, we cal-
culated a low diagnostic power of the score proposed by Hoffmayer
et al. (area under ROC curve ¼ 0.54). The differences between this
previous and the present study results may be explained by the differ-
ent inclusion criteria: Hoffmayer et al. enrolled ARVC patients with
more advanced disease phenotype and only 41% of their ARVC sam-
ple demonstrated isolated VEBs.11 Moreover, we specifically excluded
from the study ARVC patients with anterior TWI extending to lead
V3, i.e. the most important criterion for differential diagnosis in the
score proposed by Hoffmayer et al., because this is a major ARVC
diagnostic criterion14 that strongly orients towards a ‘cardiomyo-
pathic’ origin of VAs regardless of the ectopic QRS features.25
A significantly larger variance in coupling intervals was noted by
Bradfield et al.26 in VEBs arising from the aortic sinus or great cardiac
vein as opposed to those arising from the ventricular wall, which was
thought to resemble lack of restraining electrotonic coupling effects
of the surrounding myocardium, a mechanism that may also be rele-
vant in ARVC. In our study, we found similar VEB coupling intervals
between idiopathic RVOT VA and early ARVC patients, possibly be-
cause of the limited amount of fibrofatty tissue in the latter. How-
ever, in both groups, the coupling interval was variable, suggesting a
focal rather than re-entrant mechanism.
Our study has some limitations that should be acknowledged.
First, we included only desmosomal-gene mutation carriers who
show arrhythmias with a left bundle branch block/inferior axis con-
figuration and no other major ARVC features. As this condition is
rare, the study population was relatively small and this limits the stat-
istical power of the multivariate analysis. Secondly, ARVC patients
did not undergo invasive electrophysiological study to confirm the
RVOT site of origin of the arrhythmia. Thirdly, although idiopathic
RVOT-VA patients did not show any ARVC feature or positive fam-
ily history, the presence of desmosomal-gene mutations could not
be definitely excluded because genetic testing was not performed.
Finally, the design of our study is retrospective, and validation in a
prospective cohort of patients is needed.
In conclusion, our study confirmed that desmosomal-gene muta-
tion carriers with no or minimal ARVC phenotypic expression (no
major ECG or echocardiographic abnormality) may show VEBs with
a left bundle branch block/inferior axis configuration, mimicking
idiopathic and benign RVOT arrhythmias. The morphology of the
QRS in the two conditions may help differential diagnosis, and
features such as ectopic QRS axis .908 (negative QRS polarity in
lead 1), intrinsicoid deflection time .80 ms, and QS morphology
in lead V1, particularly when present in combination, should raise
high clinical suspicion of an underlying cardiomyopathy when evalu-
ating patients with apparently idiopathic RVOT VEBs to prompt
more in-depth clinical evaluation.
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